Cube Labs S.p.A., an Italian venture builder specializing in healthcare technologies and listed on Euronext Growth Milan...
Poisoned DNA or poisoning the DNA: target poison exons to treat genetic (and more?) disorders
Take home message Targeting poison exons can restore protein abundance and ameliorate the outcomes of genetic disorders ...
Planetary Health Festival | Biotechnology Pathways
October 3-4-5 – The Italian Festival of Planetary Health The Planetary Health Festival was created to raise awaren...
Next-generation psychedelics: should new agents skip the trip?
Background Depression affects around 280 million worldwide and one of the major unmet needs is the limited efficacy of t...
Vitamin B2: potential driver for cancer therapy
Cancer treatment has come a long way, but many therapies still struggle with targeting tumor cells without damaging heal...
Echoes of hope: DB-OTO gene therapy pioneers genetic hearing loss treatment DB-OTO Gene therapy: advancing treatment for genetic hearing loss
Regeneron Pharmaceuticals’ gene therapy, DB-OTO, has shown promising initial results in improving hearing for chil...